Consumer Protection Grants

505 federal consumer protection grants — 10 currently open. Filter open grants →

FDA OMHHE Health Equity Innovation Award: Enhance Equity Funding Opportunity (U01) Clinical Trials Not Allowed

Archived

Food and Drug Administration

Closes: Mar 11, 2024

OMHHE Educational Funding Opportunity: Expanding education on skin lightening products (U01) Clinical Trials Not Allowed

Archived

Food and Drug Administration

Closes: Feb 29, 2024

Strengthening Global Competency and Capacity in Inspectional Approaches for the Oversight of Human and Animal Pharmaceutical Products (U01) Clinical Trials Not Allowed

Archived

Food and Drug Administration

Closes: Feb 27, 2024

Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01) Here and Clinical Trial Designator - Clinical Trials Not Allowed

Archived

Food and Drug Administration

Closes: Feb 27, 2024

Public Health Regulatory Systems Strengthening - U01 Clinical Trials Not Allowed

Archived

Food and Drug Administration

Closes: Mar 29, 2024

OMHHE Educational Funding Opportunity: Expanding education on skin lightening products (U01) Clinical Trials Not Allowed

Forecasted

Food and Drug Administration

Strengthening Regulatory Systems to Improve Global Food and Medical Product Quality and Safety (U01) Clinical Trials Not Allowed

Archived

Food and Drug Administration

Closes: Mar 31, 2024

Natural History, Clinical Outcome Assessment, and Biomarker Studies of Rare Neurodegenerative Diseases (U01) Clinical Trials Optional

Archived

Food and Drug Administration

Closes: May 6, 2024

Implementation of U.S. Food Safety Modernization Act - Identifying, Researching and Implementing Alternative Methods to Expand the Reach Across the Global Supply Chain (U01) - Clinical Trials Not Allowed

Archived

Food and Drug Administration

Closes: Feb 19, 2024

FDA OMHHE Health Equity Innovation Award: Enhance Equity Funding Opportunity (U01) Clinical Trials Not Allowed

Forecasted

Food and Drug Administration

Critical Path Public Private Partnerships Clinical Trials Optional

Forecasted

Food and Drug Administration

Minor Use Minor Species Development of Drugs (R01)

Forecasted

Food and Drug Administration

Collaborations to Enhance Drug Development and Regulatory Science

Forecasted

Food and Drug Administration

Development and Maintenance of Human and Animal Food Rapid Response Teams (U2F) Clinical Trials Not Allowed

Forecasted

Food and Drug Administration

Utilizing Real-World Data and Algorithmic Analyses to Assess Post-Market Clinical Outcomes in Patients Switching Amongst Therapeutically Equivalent Complex Generic Drug Products and Reference Listed Drugs (U01) Clinical Trial Not Allowed

Forecasted

Food and Drug Administration

Evaluating the Cutaneous Pharmacokinetics of Topical Drug Products Using Pharmacokinetic Tomography (U01 Clinical Trial Required)

Forecasted

Food and Drug Administration

Improving Predictability of Food-Drug and Drug-Drug Interaction Risks by Utilizing In Vitro Simulated Gastrointestinal Dissolution Model for High-Risk Oral Drug Products (U01) Clinical Trial Optional

Forecasted

Food and Drug Administration

Identification of Drug-related and Formulation-Related Factors that Result in Alcohol Dose Dumping of Modified Release Oral Drug Products (U01) Clinical Trial Not Allowed

Forecasted

Food and Drug Administration

Synthesis and Biological Activity Assessment of Different Diastereomers in siRNA Drug LEQVIO (Inclisiran) (U01) Clinical Trial Not Allowed

Forecasted

Food and Drug Administration

Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01)

Forecasted

Food and Drug Administration